Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Clinical trial NCT00460811 · COMPLETED
Trial details
- NCT number
- NCT00460811
- Sponsor
- Ironwood Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2008-02-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.